Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.
The implant enables real-time intracranial pressure monitoring, cutting hospital scans by over 60%, monitoring procedures by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results